Method for treating hypophosphatemic bone diseases using FGF-23 antibody
First Claim
Patent Images
1. A method for treating X-linked hypophosphatemia (XLH), comprising the step of administering to a subject a pharmaceutical composition comprising:
- (i) an antibody that binds to a polypeptide having the amino acid sequence of SEQ ID NO;
2 or 4; and
(ii) a pharmaceutically acceptable carrier.
2 Assignments
0 Petitions
Accused Products
Abstract
A method for treating a hypophosphatemic bone disease, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition, which contains an antibody that binds to an FGF-23 polypeptide and a pharmaceutically acceptable carrier.
-
Citations
1 Claim
-
1. A method for treating X-linked hypophosphatemia (XLH), comprising the step of administering to a subject a pharmaceutical composition comprising:
-
(i) an antibody that binds to a polypeptide having the amino acid sequence of SEQ ID NO;
2 or 4; and(ii) a pharmaceutically acceptable carrier.
-
Specification